The Prescription Data product that we debuted two decades ago would scarcely recognize itself today. What started as a trail of electronic Rx clues to applicant health has grown into an interpreted-data workhorse, powerful enough to help carry insurers through the pandemic. Prescription Data has secured its place as a table-stakes risk management tool even as emerging innovations consume industry attention. But take it for granted at your peril: it remains central to your plans for innovation, growth, and business continuity.
It’s critical to you, so it’s critical to us. We work hard to ensure that Prescription Data’s protective value reigns supreme. We owe it to you to report on our progress through the years and where we are headed next.
Join Angela Bolduc, Jenna Fariss, and Dan Fleischman for a brief but sweeping report on the insurtech tool that launched a category and the ways you can depend on Prescription Data to power innovations of your own, now and tomorrow.
Wednesday, January 15, 2025, 11 a.m. Central
Topics covered
- Business continuity: Redundancy in the data source network for protection against outages, breaches, and other disruptions
- New data sources: All the various ways your applicants share their prescription histories with you and how we facilitate that sharing, including via rural and independent pharmacies, specialty drugs, and off-insurance “cash” and discount programs
- Data completeness and confidence: Review of strides forward in recency and quality
- Advances in interpretation: Condition-spectrum insights, feedback from our other tools and models, and case studies
- Q&A: Leaving time and creating space to address your questions
Who should attend
Chief executives, actuaries, underwriters, medical directors, underwriting innovation executives, and others responsible for assessing and managing risk for individual life, long-term care, disability, and Medicare Supplement insurance carriers will benefit from this webinar.
Presenters
Angela Bolduc, MBA
Principal and Managing Director
Jenna Fariss, ASA, MAAA
Director and Actuary, Solutions Consulting
Dan Fleishman, PharmD, BCPS
Principal and Director, Clinical Services